2 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
Follow Ranibizumab: new trials by email Literature Review of Ranibizumab trials Research Report on Ranibizumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multicenter Clinical Study of Anti-VEGF Treatment on High Risk Diabetic Retinopathy (DR) Ranibizumab, No drug - Diabetic Retinopathy, Ranibizumab | Phase 3 | Unknown | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 118 | 2018-04-01 | 2018-03-02 |
| Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study Intravitreal ranibizumab - Glaucoma, Neovascular, Ranibizumab | Phase 3 | Unknown | LEANDRO CABRAL ZACHARIAS | 28 | 2016-10-01 | 2016-09-27 |
Diabetic Retinopathy (1) · Glaucoma, Neovascular (1)
Eye Diseases (2) · Cardiovascular Diseases (1) · Diabetes Complications (1) · Diabetes Mellitus (1) · Diabetic Angiopathies (1) · Endocrine System Diseases (1) · Glaucoma (1) · Ocular Hypertension (1) · Retinal Diseases (1) · Vascular Diseases (1)
Ranibizumab (2)
LEANDRO CABRAL ZACHARIAS (1) · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1)
China (1)
Xun Xu (1)